跳至主要内容
临床试验/NL-OMON40581
NL-OMON40581已完成不适用

Atrial Fibrillation Reduction by Renal Sympathetic Denervation - AFFORD

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >=18 years;
  • 2. Symptomatic paroxysmal or persistent AF;
  • 3. Systolic blood pressure of 140 mmHg or more despite the use of >=2 antihypertensive drugs;
  • 4. A glomerular filtration rate of 45ml/min/1.73m2 or more;
  • 5. Written informed consent;
  • 6. The patient agrees to the follow-up including the implantation of the ICM.

排除标准

  • 1. Pregnancy;
  • 2. Renal artery abnormalities;
  • 3. First episode of AF;
  • 4. Long-term persistent or permanent AF
  • 5. The patient has other medical illness (i.e., cancer or congestive heart failure) that may cause the patient to be non-compliant with the protocol, confound the data interpretation or is associated with limited life expectancy (i.e., less than one year);

研究者

相似试验